FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990604057> ?p ?o ?g. }

• W1990604057 endingPage "746" @default.
• W1990604057 startingPage "742" @default.
• W1990604057 abstract "The role of the L-arginine-nitric oxide (NO) pathway on the formation of prostaglandin E2 (PGE2) by human cultured astroglial cells incubated with interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) was investigated. Incubation of T 67 astroglial cell line with IL-β (10 ng ml−1) and TNF-α (500 u ml−1) produced a significant (P<0.05) increase of both nitrite (the breakdown product of NO), cyclic GMP and PGE2 levels in cell supernatants. Nω-nitro-L-arginine methyl ester (L-NAME; 20–300 μM), an inhibitor of NO synthase (NOS), inhibited the increase of cyclic GMP and nitrite levels found in supernatants of cytokine-treated astroglial cells and reduced the release of PGE2. The latter effect showed that the enhanced arachidonic acid (AA) metabolism subsequent to stimulation of astroglial cells with IL-1β and TNF-α was, at least in part, induced by NO. This occurred also when sodium nitroprusside (SNP; 120 μM), an NO donor, was incubated with astroglial cells, an effect antagonized by oxyhaemoglobin (OxyHb; 10 μM). The inhibition elicited by L-NAME on PGE2-release by cytokine-treated astroglial cells was reversed by adding AA (40 μM), showing that the effect of NO on cytokine-dependent PGE2 release occurred at the cyclo-oxygenase (COX) level. Furthermore, the release of PGE2 in cytokine-treated astroglial cells was inhibited by indomethacin (10 μM), a COX inhibitor as well as by preincubating cells with dexamethasone (20 μM), an inhibitor of inducible enzymes, showing that the inducible isoform of COX (COX-2) was involved. On the other hand, pretreating astroglial cells with methylene blue (MB; 10 μM), an inhibitor of NO biological activity acting at the guanylate cyclase level, failed to affect PGE2 release in cytokine-treated astroglial cells, leading to the conclusion that cyclic GMP changes related to NO formation are not involved in the generation of AA metabolites. The present experiments demonstrated that the release of PGE2 by astroglial cells pretreated with IL-1β and TNF-α is due to enhanced COX-2 activity via activation of the L-arginine-NO pathway, and this may be relevant to the understanding of the pathophysiological mechanisms underlying neuroimmune disorders." @default.
• W1990604057 created "2016-06-24" @default.
• W1990604057 creator A5006053315 @default.
• W1990604057 creator A5026370741 @default.
• W1990604057 creator A5040339049 @default.
• W1990604057 creator A5043847254 @default.
• W1990604057 creator A5062902839 @default.
• W1990604057 creator A5065221276 @default.
• W1990604057 creator A5089443540 @default.
• W1990604057 date "1998-06-01" @default.
• W1990604057 modified "2023-10-15" @default.
• W1990604057 title "The effect of nitric oxide on cytokine-induced release of PGE₂by human cultured astroglial cells" @default.
• W1990604057 cites W1568750314 @default.
• W1990604057 cites W1974505155 @default.
• W1990604057 cites W1974975160 @default.
• W1990604057 cites W1983094606 @default.
• W1990604057 cites W1984590860 @default.
• W1990604057 cites W1988031989 @default.
• W1990604057 cites W1989039499 @default.
• W1990604057 cites W1991219972 @default.
• W1990604057 cites W2011326096 @default.
• W1990604057 cites W2016585694 @default.
• W1990604057 cites W2019154730 @default.
• W1990604057 cites W2034555465 @default.
• W1990604057 cites W2044698897 @default.
• W1990604057 cites W2051776016 @default.
• W1990604057 cites W2062137913 @default.
• W1990604057 cites W2067286503 @default.
• W1990604057 cites W2075068003 @default.
• W1990604057 cites W2079806280 @default.
• W1990604057 cites W2082350804 @default.
• W1990604057 cites W2083873191 @default.
• W1990604057 cites W2089747387 @default.
• W1990604057 cites W2116166509 @default.
• W1990604057 cites W2122400789 @default.
• W1990604057 cites W2132582699 @default.
• W1990604057 cites W2138029683 @default.
• W1990604057 doi "https://doi.org/10.1038/sj.bjp.0701852" @default.
• W1990604057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1565428" @default.
• W1990604057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9690866" @default.
• W1990604057 hasPublicationYear "1998" @default.
• W1990604057 type Work @default.
• W1990604057 sameAs 1990604057 @default.
• W1990604057 citedByCount "58" @default.
• W1990604057 countsByYear W19906040572012 @default.
• W1990604057 countsByYear W19906040572013 @default.
• W1990604057 countsByYear W19906040572014 @default.
• W1990604057 countsByYear W19906040572015 @default.
• W1990604057 countsByYear W19906040572018 @default.
• W1990604057 countsByYear W19906040572020 @default.
• W1990604057 countsByYear W19906040572022 @default.
• W1990604057 crossrefType "journal-article" @default.
• W1990604057 hasAuthorship W1990604057A5006053315 @default.
• W1990604057 hasAuthorship W1990604057A5026370741 @default.
• W1990604057 hasAuthorship W1990604057A5040339049 @default.
• W1990604057 hasAuthorship W1990604057A5043847254 @default.
• W1990604057 hasAuthorship W1990604057A5062902839 @default.
• W1990604057 hasAuthorship W1990604057A5065221276 @default.
• W1990604057 hasAuthorship W1990604057A5089443540 @default.
• W1990604057 hasBestOaLocation W19906040572 @default.
• W1990604057 hasConcept C134018914 @default.
• W1990604057 hasConcept C153911025 @default.
• W1990604057 hasConcept C17991360 @default.
• W1990604057 hasConcept C181199279 @default.
• W1990604057 hasConcept C185592680 @default.
• W1990604057 hasConcept C203014093 @default.
• W1990604057 hasConcept C2777198256 @default.
• W1990604057 hasConcept C2777622882 @default.
• W1990604057 hasConcept C2777956040 @default.
• W1990604057 hasConcept C2778078955 @default.
• W1990604057 hasConcept C2778690821 @default.
• W1990604057 hasConcept C2779610285 @default.
• W1990604057 hasConcept C519581460 @default.
• W1990604057 hasConcept C54355233 @default.
• W1990604057 hasConcept C55493867 @default.
• W1990604057 hasConcept C81885089 @default.
• W1990604057 hasConcept C86803240 @default.
• W1990604057 hasConceptScore W1990604057C134018914 @default.
• W1990604057 hasConceptScore W1990604057C153911025 @default.
• W1990604057 hasConceptScore W1990604057C17991360 @default.
• W1990604057 hasConceptScore W1990604057C181199279 @default.
• W1990604057 hasConceptScore W1990604057C185592680 @default.
• W1990604057 hasConceptScore W1990604057C203014093 @default.
• W1990604057 hasConceptScore W1990604057C2777198256 @default.
• W1990604057 hasConceptScore W1990604057C2777622882 @default.
• W1990604057 hasConceptScore W1990604057C2777956040 @default.
• W1990604057 hasConceptScore W1990604057C2778078955 @default.
• W1990604057 hasConceptScore W1990604057C2778690821 @default.
• W1990604057 hasConceptScore W1990604057C2779610285 @default.
• W1990604057 hasConceptScore W1990604057C519581460 @default.
• W1990604057 hasConceptScore W1990604057C54355233 @default.
• W1990604057 hasConceptScore W1990604057C55493867 @default.
• W1990604057 hasConceptScore W1990604057C81885089 @default.
• W1990604057 hasConceptScore W1990604057C86803240 @default.
• W1990604057 hasIssue "4" @default.
• W1990604057 hasLocation W19906040571 @default.
• W1990604057 hasLocation W19906040572 @default.
• W1990604057 hasLocation W19906040573 @default.

• next